During the past decade, Centro de Estudios Clínicos e Investigación Médica (CeCim) conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Estudios Clínicos e Investigación Médica (CeCim)" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "CanariaBio Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Estudios Clínicos e Investigación Médica (CeCim)" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Estudios Clínicos e Investigación Médica (CeCim)" are "Crohn's Disease" (2 trials), "Depressive Disorder, Major" (2 trials), "Carcinoma, Ovarian Epithelial" (1 trials), "Colitis, Ulcerative" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Centro de Estudios Clínicos e Investigación Médica (CeCim)" in a lesser frequency.

Most popular intervention types in "Centro de Estudios Clínicos e Investigación Médica (CeCim)" are "Drug" (9 trials), "Biological" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Seltorexant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Estudios Clínicos e Investigación Médica (CeCim)" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro de Estudios Clínicos e Investigación Médica (CeCim)". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro de Estudios Clínicos e Investigación Médica (CeCim), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Estudios Clínicos e Investigación Médica (CeCim), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".